Infosys' stock rises toward 6-month high, and longest monthly win streak in 9 years
Shares of Infosys Ltd. (500209.BY) rose 0.5% toward a six-month high in morning trading Tuesday, to buck the selloff in the technology sector and the broader stock market. The information-technology consultant's stock has now gained 3.9% so far in September, putting it on track for a fifth-straight monthly gain, which would be the longest such streak since the six-month win streak that ended November 2014. Meanwhile, the Technology Select Sector SPDR ETF (XLK) was down 1.3% and the S&P 500 was off by 0.5%. The stock's rally Tuesday comes after President Joe Biden wrapped up a trip to Vietnam and India this week -- the Group of 20 summit over the weekend was held in New Delhi -- as he looked to strengthen partnerships and develop new collaborations with the countries, while denying it was to fend off China's attempts to increase its influence in the region. Infosys's stock has now run up 22.0% since it closed at a 2 1/2-year low of $14.79 on April 25, compared with a 12.6% gain in the iShares MSCI India ETF (INDA) and a 9.7% advance in the S&P 500 over the same time.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-12-23 1107ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk